Other reports demonstrated variable expression of PD-L1 on clonal plasma cells at different stages of disease from newly diagnosed MGUS and MM, to patients with persistent measurable residual disease (MRD) post-intensive therapy to relapsed MM, indicating upregulation of PD-L1 is associated with worse outcomes of MM [23]. The gene discussed is CD274; the disease is Miyoshi myopathy.